Wells Fargo Downgrades West Pharmaceutical (WST) to Market Perform

September 21, 2016 6:57 AM EDT
Get Alerts WST Hot Sheet
Price: $71.68 -1.12%

Rating Summary:
    1 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 11 | New: 8
Trade WST Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Wells Fargo downgraded West Pharmaceutical (NYSE: WST) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on West Pharmaceutical click here. For more ratings news on West Pharmaceutical click here.

Shares of West Pharmaceutical closed at $81.32 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Wells Fargo

Add Your Comment